15-Jan-2026
No headlines found.
No press releases found.
No news found.
The Fund's primary investment objective is to seek current income. The Fund's secondary investment objective is to seek exposure to the share price of the common stock of Moderna, Inc. ("MRNA" or "Underlying Security"), subject to a limit on potential investment gains. The Fund is an actively managed exchange-traded fund ("ETF") that seeks current income while providing indirect exposure to the share price (i.e., the price returns) of the common stock of Moderna, Inc. ("MRNA" or the "Underlying Security"), subject to a limit on potential investment gains. The Fund will employ its investment strategy as it relates to MRNA regardless of whether there are periods of adverse market, economic, or other conditions and will take temporary defensive positions during such periods. As further described below, the Fund uses either a synthetic covered call strategy or a synthetic covered call spread strategy to provide income and indirect exposure to the share price returns of MRNA, subject to a limit on potential investment gains as a result of the nature of the options strategy it employs. That is, the Fund not only seeks to generate income from its options investments but also aims to derive gains when the value of MRNA increases.
Yieldmax Mrna Option Income Strategy ETF trades on the ARCA stock market under the symbol MRNY.
As of January 15, 2026, MRNY stock price declined to $18.01 with 120,584 million shares trading.
MRNY has a beta of 1.28, meaning it tends to be more sensitive to market movements. MRNY has a correlation of 0.16 to the broad based SPY ETF.
MRNY has a market cap of $87.89 million. This is considered a Micro Cap stock.
MRNY has underperformed the market in the last year with a return of -9.3%, while SPY returned +18.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MRNY shares. However, MRNY has outperformed the market in the last 3 month and 2 week periods, returning +24.8% and +27.9%, while SPY returned +4.4% and +1.5%, respectively. This indicates MRNY has been having a stronger performance recently.
MRNY support price is $17.60 and resistance is $19.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRNY shares will trade within this expected range on the day.
